MR1 overexpression correlates with poor clinical prognosis in glioma patients.
Neuro-oncology advances(2021)
摘要
Our in silico analysis shows that expression is a predictor of clinical outcome in glioma patients and is potentially regulated at the epigenetic level, resulting in immune-related genes dysregulation. These findings need to be validated using independent in vitro and in vivo functional studies.
更多查看译文
关键词
MR1,glioblastoma,glioma,methylation,survival
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要